T. Comoglu Et Al. , "Formulation and evaluation of diclofenac potassium fast-disintegrating tablets and their clinical application in migraine patients," DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY , vol.37, no.3, pp.260-267, 2011
Comoglu, T. Et Al. 2011. Formulation and evaluation of diclofenac potassium fast-disintegrating tablets and their clinical application in migraine patients. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY , vol.37, no.3 , 260-267.
Comoglu, T., DOĞAN, A., Comoglu, S., & Basci, N. E., (2011). Formulation and evaluation of diclofenac potassium fast-disintegrating tablets and their clinical application in migraine patients. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY , vol.37, no.3, 260-267.
Comoglu, Tansel Et Al. "Formulation and evaluation of diclofenac potassium fast-disintegrating tablets and their clinical application in migraine patients," DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY , vol.37, no.3, 260-267, 2011
Comoglu, Tansel Et Al. "Formulation and evaluation of diclofenac potassium fast-disintegrating tablets and their clinical application in migraine patients." DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY , vol.37, no.3, pp.260-267, 2011
Comoglu, T. Et Al. (2011) . "Formulation and evaluation of diclofenac potassium fast-disintegrating tablets and their clinical application in migraine patients." DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY , vol.37, no.3, pp.260-267.
@article{article, author={Tansel Comoglu Et Al. }, title={Formulation and evaluation of diclofenac potassium fast-disintegrating tablets and their clinical application in migraine patients}, journal={DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY}, year=2011, pages={260-267} }